ParisRoachMD

PubMed

• Protein targeting to glycogen is a master regulator of glycogen synthesis in astrocytes.
  Ruchti, E.,Roach, P. J.,DePaoli-Roach, A. A.,Magistretti, P. J.,Allaman, I.> ;IBRO Rep. 2016 Oct 04
• 32 citations
  Euglycemic Diabetic Ketoacidosis in a Patient With Type 2 Diabetes After Treatment With Empagliflozin
  Paris Roach, Paul A. Skierczynski> ;Diabetes Care. 2016 Jan 1
• 8 citations
  Listening to patients' voices: linguistic indicators related to diabetes self-management.
  Ulla Connor, Marta Antón, Elizabeth M. Goering, Kathryn Lauten, Paris Roach, Stephanie Balunda, Amir Hayat> ;Communication in medicine. 2013 Feb 19
• 26 citations
  Genetic Modulation of Lipid Profiles following Lifestyle Modification or Metformin Treatment: The Diabetes Prevention Program
  Toni I. Pollin, Tamara Isakova, Kathleen A. Jablonski, Paul I.W. de Bakker, Andrew W. Taylor, Jarred McAteer, Qing Pan, Edward S. Horton, L. Delahanty, David Altshuler...> ;PLOS Genetics. 2012 Aug 1
• 79 citations
  Exenatide added to insulin therapy: a retrospective review of clinical practice over two years in an academic endocrinology outpatient setting.
  Nancy M. Yoon, Melissa K. Cavaghan, Rocco L. Brunelle, Paris Roach> ;Clinical Therapeutics. 2009 Jul 1
• 22 citations
  Investing time in health: do socioeconomically disadvantaged patients spend more or less extra time on diabetes self‐care?
  Susan L. Ettner, Betsy L. Cadwell, Louise B. Russell, Arleen F. Brown, Andrew J. Karter, Monika M. Safford, Carol Mangione, Gloria L. Beckles, William H. Herman, Theod...> ;Health Economics. 2009 Jun 1
• 21 citations
  New insulin analogues and routes of delivery: pharmacodynamic and clinical considerations.
  Paris Roach> ;Clinical Pharmacokinectics. 2008 Jan 1
• 13 citations
  Comparison of insulin lispro mixture 25/75 with insulin glargine during a 24-h standardized test-meal period in patients with Type 2 diabetes
  Peter J. Roach, J. K. Malone> ;Diabetic Medicine. 2006 Jul 1
• 10 citations
  A Critical Dialogue: Communicating with Type 2 Diabetes Patients about Cardiovascular Risk
  Paris Roach, David G. Marrero> ;Vascular Health and Risk Management. 2005 Jan 1
• 2 citations
  Better systems, not guidelines, for glucose monitoring
  Paris Roach> ;BMJ. 2004 Dec 9
• 7 citations
  Effects of multiple daily injection therapy with Humalog mixtures versus separately injected insulin lispro and NPH insulin in adults with type I diabetes mellitus.
  Paris Roach, Shan Bai, Bernard Charbonnel, Agostino Consoli, Claudio Taboga, Antonio Tiengo, Geremia B. Bolli> ;Clinical Therapeutics. 2004 Apr 1
• Good diabetes care: more than cheap meds.
  Ronald T. Ackermann, Paris Roach, David G. Marrero> ;Medical Care. 2004 Feb 1
• 2 citations
  A 75% insulin lispro/25% NPL mixture provides a longer duration of insulin activity compared with insulin lispro alone in patients with Type 1 diabetes.
  Paris Roach, James R. Woodworth, U. Gudat, B. Cerimele, F. Diebler, M. Pein, M. Dreyer> ;Diabetic Medicine. 2003 Nov 1
• 30 citations
  Clinical pharmacokinetics and pharmacodynamics of insulin lispro mixtures.
  Paris Roach, James R. Woodworth> ;Clinical Pharmacokinectics. 2002 Jan 1
• 15 citations
  Glycemic control with Humalog Mix25 in type 2 diabetes inadequately controlled with glyburide.
  Paris Roach, Ekaterina Koledova, Stephen Metcalfe, Cheryl Hultman, Zvonko Milicevic> ;Clinical Therapeutics. 2001 Oct 1
• 88 citations
  Improved postprandial glycemic control during treatment with Humalog Mix25, a novel protamine-based insulin lispro formulation. Humalog Mix25 Study Group.
  Paris Roach, Lilly Q. Yue, Vipin Arora> ;Diabetes Care. 1999 Aug 1
• 62 citations
  Improved postprandial blood glucose control and reduced nocturnal hypoglycemia during treatment with two novel insulin lispro-protamine formulations, insulin lispro Mi...
  Paris Roach, Michael E. Trautmann, Vipin Arora, Bin Sun, James H. Anderson> ;Clinical Therapeutics. 1999 Mar 1
• 1 citations
  A note on the sample size determination in two-period repeated measurements crossover design with application to clinical trials.
  Lilly Q. Yue, Paris Roach> ;Journal of Biopharmaceutical Statistics. 1998 Jan 1
• 10 citations
  Sonography of gallbladder abnormalities in acromegaly patients following octreotide and ursodiol therapy: incidence and time course.
  Nilo A. Avila, Thomas H. Shawker, Paris Roach, Mary H. Bradford, Monica C. Skarulis, Richard T. Eastman> ;Journal of Clinical Ultrasound. 1998 Jul 1
• 64 citations
  Time-Action Profiles of Novel Premixed Preparations of Insulin Lispro and NPL Insulin
  Tim Heise, Christian Weyer, Andreas Serwas, Sebastian Heinrichs, Johannes Osinga, Paris Roach, Jim Woodworth, Uwe Gudat, Lutz Heinemann> ;Diabetes Care. 1998 May 1
• 16 citations
  Nighttime Insulin Kinetics and Glycemic Control in Type 1 Diabetes Patients Following Administration of an Intermediate-Acting Lispro Preparation
  Maureen M. J. Janssen, Sandrina Casteleijn, Walter Devillé, Corrie Popp-Snijders, Paris Roach, Robert J. Heine> ;Diabetes Care. 1997 Dec 1
• 34 citations
  Plasma proinsulin-like component in insulinoma: a 25-year experience
  P Gorden, Monica C. Skarulis, Paris Roach, Richard J. Comi, Douglas L. Fraker, Jeffrey A. Norton, H R Alexander, John L. Doppman> ;The Journal of Clinical Endocrinology and Metabolism. 1995 Oct 1
• 11 citations
  Rescue and activation of a binding-deficient insulin receptor. Evidence for intermolecular transphosphorylation.
  Mohammed Taouis, Rachel Levy-Toledano, Paris Roach, Simeon I. Taylor, Phillip Gorden> ;Journal of Biological Chemistry. 1994 Nov 4
• 40 citations
  A Novel Human Insulin Receptor Gene Mutation Uniquely Inhibits Insulin Binding Without Impairing Posttranslational Processing
  Paris Roach, Yehiel Zick, Pietro Formisano, Domenico Accili, Simeon I. Taylor, Phillip Gorden> ;Diabetes. 1994 Sep 1
• 20 citations
  Structural basis by which a recessive mutation in the alpha-subunit of the insulin receptor affects insulin binding.
  Mohammed Taouis, Rachel Levy-Toledano, Paris Roach, Simeon I. Taylor, Phillip Gorden> ;Journal of Biological Chemistry. 1994 May 27
• Join now to see all